Teva to pay $225M to settle cholesterol drug price-fixing charges | AP News
Teva Reports Fourth Quarter and Full Year 2022 Financial Results | Business Wire
Teva Pharmaceuticals Will Pay Up To $523 Million In New York For Opioid Settlement
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Pharmaceutical: Generic Market Access to Global Healthcare Industry | IntechOpen
Teva reaches $523 million deal to settle opioid lawsuit with New York | CNN Business
Teva, Kirkland & Ellis Challenge Colorado's Epipen 'Affordability Program' | Law.com
Teva to pay $225 mln, divest cholesterol drug to settle price-fixing charges | Reuters
Teva CEO exits in ongoing crisis of confidence at drugmaker | Reuters
Teva reaches $4.25 billion settlement over alleged role in opioid crisis - CBS News
Nobody Thought It Would Come to This': Drug Maker Teva Faces a Crisis - The New York Times
Teva's Trouble Was Predicted. Path to Recovery Not as Clear - Bloomberg
Teva Pharmaceuticals - Wikipedia
Opioid crisis: Pharmaceutical company Teva agrees to $250M settlement | Fox Business Video
Teva | Partnership | Direct Relief
Teva stock pops on Q2 results, CEO sees 'significant' potential for trio of branded drugs - YouTube
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva reaches $126M opioid settlement with hospitals - Top Class Actions
What does Teva's growth strategy look like?
Teva Pharmaceutical (NYSE:TEVA) Says Business Unaffected by Israel-Palestine War - TipRanks.com
Teva to pay US millions in price-fixing settlement
Decoding Teva Pharmaceutical Industries Ltd (TEVA): A Strategic SWOT Insight
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
Teva Settles Oklahoma Opioid Case for $85 Million - WSJ
